Overview

Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.
Phase:
Phase 4
Details
Lead Sponsor:
Zogenix, Inc.
Collaborator:
Synteract, Inc.
Treatments:
Sumatriptan